These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 14769215)
1. Effects of chebulinic acid on differentiation of human leukemia K562 cells. Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells. Yi Z; Wang Z; Li H; Liu M Toxicol Lett; 2004 Mar; 147(2):109-19. PubMed ID: 14757314 [TBL] [Abstract][Full Text] [Related]
3. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
7. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628 [TBL] [Abstract][Full Text] [Related]
8. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation. Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117 [TBL] [Abstract][Full Text] [Related]
9. A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells. Wang D; Li Y; Shen B Chin Med J (Engl); 2002 Nov; 115(11):1701-5. PubMed ID: 12609092 [TBL] [Abstract][Full Text] [Related]
10. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells. Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425 [TBL] [Abstract][Full Text] [Related]
11. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells. Tahara T; Sun J; Igarashi K; Taketani S Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines. Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954 [TBL] [Abstract][Full Text] [Related]
15. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248 [TBL] [Abstract][Full Text] [Related]
16. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives. Szulawska A; Arkusinska J; Czyz M Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070 [TBL] [Abstract][Full Text] [Related]
17. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674 [TBL] [Abstract][Full Text] [Related]
19. Over-expression of EDAG in the myeloid cell line 32D: induction of GATA-1 expression and erythroid/megakaryocytic phenotype. Ding YL; Xu CW; Wang ZD; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Li CY; Yang XM J Cell Biochem; 2010 Jul; 110(4):866-74. PubMed ID: 20564185 [TBL] [Abstract][Full Text] [Related]
20. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7. Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]